Global Nutrigenomics Market By Type (Health Test, Sports Test, Fertility Test, Plant-Based); By End-Users (Clubs, Health and Fitness Professionals, Wellness Companies, Others); By Application (Obesity, Cardiovascular Disease (CVD), Diabetes Mellitus (DM), Cancer, Others); By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2021 – 2029
Industry Trends
Human beings have tried to obtain proper sources of nutrition since time immemorial. The advancement in science experiments related to nutrition has seen huge progress in the last 25 years. Scientists are increasingly trying to understand the relation between a proper diet plan and human performance. Evidence suggests that a balanced nutrition program is essential for maximizing human performance in fields like sports, academics and disease prevention, amongst others. However, change in lifestyle and modernization has also lead to the rise in non-communicable diseases such as cancer, diabetes, cardiovascular disease, amongst others. Studies show that several diseases can be controlled, or mitigated, using a healthy dietary plan. However, the genetic composition of each individual is different, and personalized diet plan need to be provided maximizing performance. This is where the field of nutrigenomics becomes important. Nutrigenomics deals with the relation and interaction between genetic composition and nutrition. Commonly, nutrigenomics is associated with genetic disorders that prevents the human body from turning food into an energy source by breaking down food particles. After the industrial revolution, numerous individuals have been victims of non communicable diseases, and scientists believe that nutrigenomics-based approach can play a vital role in controlling the effects of non communicable diseases in humans, thus driving the nutrigenomics market growth.
The COVID-19 pandemic has drastically changed the lives of millions of individuals around the globe. Statistics show that the Coronavirus has lead to the death of over 4.5 million individuals thus far, and the mutation of the virus is causing more worry amongst government bodies, despite the rolling out of the COVID-19 vaccine. Studies show that individuals with comorbidity conditions are most likely to face the brunt of the pandemic, and health issues like diabetes, cardiovascular disease, etc., can be aggravated after contacting the virus. In fact, the many deaths are being reported as a result of various underlying conditions in the human body. The U.S. Department of Health & Human Services reported that vaccines should initially be rolled out to individuals who have underlying health conditions, as they are at an increased risk of having severe illness due to the coronavirus. Nutrigenomics research becomes extremely important in these cases, as it has the potential to reduce the impact of such viral diseases by tackling issues like diabetes, cancer, amongst others. The main aim of nutrigenomics during these challenging times is the personalization of medicines and nutrition, which ultimately leads to a better health condition in humans. It also talks about the enhancement of immunity in individuals based on their genotype by the administration of certain nutrients. Thus, these factors are propelling the demand of nutrigenomics market during the COVID-19 pandemic.
In terms of revenue, nutrigenomics market was is expected to grow at a CAGR of 19.87% over the forecast period (2021 – 2029). The study analyses the market in terms of revenue across all the major regions, which have been bifurcated into countries.
Nutrigenomics Market Revenue & Forecast, (US$ Million), 2015 – 2029
Application Outlook:
Nutrigenomics can be used for various applications such as the mitigation of conditions like obesity, cardiovascular diseases, diabetes mellitus and cancer, amongst others. Cases of diabetes has seen a significant spike in recent years, especially in low and middle income countries. In 1980, around 108 million cases of diabetes were reported globally, while the number rose to 422 million in 2014. It is a major cause of conditions such as kidney failure, limb amputation, stroke, and blindness. Stats from the World Health Organization show that around 1.5 million deaths were reported directly as a consequence of diabetes in 2019. Furthermore, around 2.2 million additional deaths could be attributed to the rise in high blood glucose levels. Proper diet and exercise plays a vital rose in controlling diabetes. Diabetes mellitus stems from defects in insulin secretion or insulin activity, or a combination of both, and is characterized by a condition called as hyperglycemia. Obese individuals are expected to be at a greater risk of acquiring diabetes by a factor of 10, as opposed to a normal individual. Developing countries have reported a rise in diabetes cases, mainly due to the shift from traditional diet to modernized fast food-based diet, especially processed, oily foods. Irregular secretion of insulin has been observed in the case of obesity and type 2 diabetes mellitus. Therefore, understanding the genomics of individuals can play a vital role in controlling the spread of diabetes, and consequent health conditions. Advanced research is being conducted in the reduction of diabetes through nutrigenomics, which in turn can help in the reduction of diabetes and obesity, especially in young adults. Therefore, the importance of nutrigenomics market in the field of diabetes and obesity is expected to see considerable growth in the coming years.
Region Outlook:
North America accounted for the highest share in the global nutrigenomics market in 2020. The higher awareness about nutrigenomics amongst the end-users, coupled with the presence of prominent companies that are offering nutrigenomics services plays a vital role in North America being the most important region in terms of revenue in the global nutrigenomics market. Companies are increasingly investing in nutrigenomics services, especially for performance enhancement and personalized diet recommendations. These factors are especially useful in the field of athlete training, disease treatment and prevention and performance maximization in kids, amongst others.
Competitive Landscape
The report provides both, qualitative and quantitative research of nutrigenomics market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of key players operating in the nutrigenomics market are Alltech, Cell-Logic, Cura Integrative Medicine, geneOmbio Technologies Pvt. Ltd., Genova Diagnostics (GDX), Genova Diagnostics, Metagenics, Inc., Nutrigenomix, Sanger Genomics Pvt. Ltd, Wellgen Medical Co., Ltd., and other market participants.
Nutrigenomics Market
By Type
- Health Test
- Sports Test
- Fertility Test
- Plant-Based
By End-Users
- Clubs
- Health and Fitness Professionals
- Wellness Companies
- Others
By Application
- Obesity
- Cardiovascular Disease (CVD)
- Diabetes Mellitus (DM)
- Cancer
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Rest of North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Denmark
- Finland
- Iceland
- Sweden
- Norway
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
1.
Market
Scope
1.1. Market Segmentation
1.2. Years Considered
1.2.1. Historic Years: 2015 - 2019
1.2.2. Base Year: 2020
1.2.3. Forecast Years: 2021 – 2029
2.
Key
Target Audiences
3.
Research
Methodology
3.1. Primary Research
3.1.1. Research Questionnaire
3.1.2. Global Percentage Breakdown
3.1.3. Primary Interviews: Key Opinion Leaders
(KOLs)
3.2. Secondary Research
3.2.1. Paid Databases
3.2.2. Secondary Sources
3.3. Market Size Estimates
3.3.1. Top-Down Approach
3.3.2. Bottom-Up Approach
3.4. Data Triangulation Methodology
3.5. Research Assumptions
4.
Recommendations
and Insights from AMI’s Perspective**
5.
Holistic
Overview of Nutrigenomics Market
6.
Market
Synopsis: Nutrigenomics Market
7.
Nutrigenomics
Market Analysis: Qualitative Perspective
7.1. Introduction
7.1.1. Product Definition
7.1.2. Industry Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.2.4. Challenges
7.3. Trends in Nutrigenomics Market
7.4. Market Determinants Radar Chart
7.5. Macro-Economic and Micro-Economic Indicators:
Nutrigenomics Market
7.6. Industry Gross Margin Overview
7.7. Porter’s Five Force Analysis
7.8. Impact of Covid-19 on Nutrigenomics Market
8.
Global
Nutrigenomics Market Analysis and Forecasts, 2021 – 2029
8.1. Overview
8.1.1. Global Nutrigenomics Market Revenue (US$ Mn)
8.2. Global Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
8.2.1. Health Test
8.2.1.1.
Definition
8.2.1.2.
Market Estimation
and Penetration, 2015 - 2020
8.2.1.3.
Market
Forecast, 2021 - 2029
8.2.1.4.
Compound
Annual Growth Rate (CAGR)
8.2.1.5.
Regional
Bifurcation
8.2.1.5.1.
North
America
8.2.1.5.1.1. Market Estimation, 2015 - 2020
8.2.1.5.1.2. Market Forecast, 2021 - 2029
8.2.1.5.2.
Europe
8.2.1.5.2.1. Market Estimation, 2015 - 2020
8.2.1.5.2.2. Market Forecast, 2021 - 2029
8.2.1.5.3.
Asia
Pacific
8.2.1.5.3.1. Market Estimation, 2015 - 2020
8.2.1.5.3.2. Market Forecast, 2021 - 2029
8.2.1.5.4.
Middle
East and Africa
8.2.1.5.4.1. Market Estimation, 2015 - 2020
8.2.1.5.4.2. Market Forecast, 2021 - 2029
8.2.1.5.5.
Latin
America
8.2.1.5.5.1. Market Estimation, 2015 - 2020
8.2.1.5.5.2. Market Forecast, 2021 - 2029
8.2.2. Sports Test
8.2.2.1.
Definition
8.2.2.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.2.3.
Market
Forecast, 2021 - 2029
8.2.2.4.
Compound
Annual Growth Rate (CAGR)
8.2.2.5.
Regional
Bifurcation
8.2.2.5.1.
North
America
8.2.2.5.1.1. Market Estimation, 2015 - 2020
8.2.2.5.1.2. Market Forecast, 2021 - 2029
8.2.2.5.2.
Europe
8.2.2.5.2.1. Market Estimation, 2015 - 2020
8.2.2.5.2.2. Market Forecast, 2021 - 2029
8.2.2.5.3.
Asia
Pacific
8.2.2.5.3.1. Market Estimation, 2015 - 2020
8.2.2.5.3.2. Market Forecast, 2021 - 2029
8.2.2.5.4.
Middle
East and Africa
8.2.2.5.4.1. Market Estimation, 2015 - 2020
8.2.2.5.4.2. Market Forecast, 2021 - 2029
8.2.2.5.5.
Latin
America
8.2.2.5.5.1. Market Estimation, 2015 - 2020
8.2.2.5.5.2. Market Forecast, 2021 - 2029
8.2.3. Fertility Test
8.2.3.1.
Definition
8.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.3.3.
Market
Forecast, 2021 - 2029
8.2.3.4.
Compound
Annual Growth Rate (CAGR)
8.2.3.5.
Regional
Bifurcation
8.2.3.5.1.
North
America
8.2.3.5.1.1. Market Estimation, 2015 - 2020
8.2.3.5.1.2. Market Forecast, 2021 - 2029
8.2.3.5.2.
Europe
8.2.3.5.2.1. Market Estimation, 2015 - 2020
8.2.3.5.2.2. Market Forecast, 2021 - 2029
8.2.3.5.3.
Asia
Pacific
8.2.3.5.3.1. Market Estimation, 2015 - 2020
8.2.3.5.3.2. Market Forecast, 2021 - 2029
8.2.3.5.4.
Middle
East and Africa
8.2.3.5.4.1. Market Estimation, 2015 - 2020
8.2.3.5.4.2. Market Forecast, 2021 - 2029
8.2.3.5.5.
Latin
America
8.2.3.5.5.1. Market Estimation, 2015 - 2020
8.2.3.5.5.2. Market Forecast, 2021 - 2029
8.2.4. Plant-Based
8.2.4.1.
Definition
8.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
8.2.4.3.
Market
Forecast, 2021 - 2029
8.2.4.4.
Compound
Annual Growth Rate (CAGR)
8.2.4.5.
Regional
Bifurcation
8.2.4.5.1.
North
America
8.2.4.5.1.1. Market Estimation, 2015 - 2020
8.2.4.5.1.2. Market Forecast, 2021 - 2029
8.2.4.5.2.
Europe
8.2.4.5.2.1. Market Estimation, 2015 - 2020
8.2.4.5.2.2. Market Forecast, 2021 - 2029
8.2.4.5.3.
Asia
Pacific
8.2.4.5.3.1. Market Estimation, 2015 - 2020
8.2.4.5.3.2. Market Forecast, 2021 - 2029
8.2.4.5.4.
Middle
East and Africa
8.2.4.5.4.1. Market Estimation, 2015 - 2020
8.2.4.5.4.2. Market Forecast, 2021 - 2029
8.2.4.5.5.
Latin
America
8.2.4.5.5.1. Market Estimation, 2015 - 2020
8.2.4.5.5.2. Market Forecast, 2021 - 2029
8.3. Key Segment for Channeling Investments
8.3.1. By Type
9.
Global
Nutrigenomics Market Analysis and Forecasts, 2021 – 2029
9.1. Overview
9.2. Global Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
9.2.1. Clubs
9.2.1.1.
Definition
9.2.1.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.1.3.
Market
Forecast, 2021 - 2029
9.2.1.4.
Compound
Annual Growth Rate (CAGR)
9.2.1.5.
Regional
Bifurcation
9.2.1.5.1.
North
America
9.2.1.5.1.1. Market Estimation, 2015 - 2020
9.2.1.5.1.2. Market Forecast, 2021 - 2029
9.2.1.5.2.
Europe
9.2.1.5.2.1. Market Estimation, 2015 - 2020
9.2.1.5.2.2. Market Forecast, 2021 - 2029
9.2.1.5.3.
Asia
Pacific
9.2.1.5.3.1. Market Estimation, 2015 - 2020
9.2.1.5.3.2. Market Forecast, 2021 - 2029
9.2.1.5.4.
Middle
East and Africa
9.2.1.5.4.1. Market Estimation, 2015 - 2020
9.2.1.5.4.2. Market Forecast, 2021 - 2029
9.2.1.5.5.
Latin
America
9.2.1.5.5.1. Market Estimation, 2015 - 2020
9.2.1.5.5.2. Market Forecast, 2021 - 2029
9.2.2. Health and Fitness Professionals
9.2.2.1.
Definition
9.2.2.2.
Market Estimation
and Penetration, 2015 - 2020
9.2.2.3.
Market
Forecast, 2021 - 2029
9.2.2.4.
Compound
Annual Growth Rate (CAGR)
9.2.2.5.
Regional
Bifurcation
9.2.2.5.1.
North
America
9.2.2.5.1.1. Market Estimation, 2015 - 2020
9.2.2.5.1.2. Market Forecast, 2021 - 2029
9.2.2.5.2.
Europe
9.2.2.5.2.1. Market Estimation, 2015 - 2020
9.2.2.5.2.2. Market Forecast, 2021 - 2029
9.2.2.5.3.
Asia
Pacific
9.2.2.5.3.1. Market Estimation, 2015 - 2020
9.2.2.5.3.2. Market Forecast, 2021 - 2029
9.2.2.5.4.
Middle
East and Africa
9.2.2.5.4.1. Market Estimation, 2015 - 2020
9.2.2.5.4.2. Market Forecast, 2021 - 2029
9.2.2.5.5.
Latin
America
9.2.2.5.5.1. Market Estimation, 2015 - 2020
9.2.2.5.5.2. Market Forecast, 2021 - 2029
9.2.3. Wellness Companies
9.2.3.1.
Definition
9.2.3.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.3.3.
Market
Forecast, 2021 - 2029
9.2.3.4.
Compound
Annual Growth Rate (CAGR)
9.2.3.5.
Regional
Bifurcation
9.2.3.5.1.
North
America
9.2.3.5.1.1. Market Estimation, 2015 - 2020
9.2.3.5.1.2. Market Forecast, 2021 - 2029
9.2.3.5.2.
Europe
9.2.3.5.2.1. Market Estimation, 2015 - 2020
9.2.3.5.2.2. Market Forecast, 2021 - 2029
9.2.3.5.3.
Asia
Pacific
9.2.3.5.3.1. Market Estimation, 2015 - 2020
9.2.3.5.3.2. Market Forecast, 2021 - 2029
9.2.3.5.4.
Middle
East and Africa
9.2.3.5.4.1. Market Estimation, 2015 - 2020
9.2.3.5.4.2. Market Forecast, 2021 - 2029
9.2.3.5.5.
Latin
America
9.2.3.5.5.1. Market Estimation, 2015 - 2020
9.2.3.5.5.2. Market Forecast, 2021 - 2029
9.2.4. Others
9.2.4.1.
Definition
9.2.4.2.
Market
Estimation and Penetration, 2015 - 2020
9.2.4.3.
Market
Forecast, 2021 - 2029
9.2.4.4.
Compound
Annual Growth Rate (CAGR)
9.2.4.5.
Regional
Bifurcation
9.2.4.5.1.
North
America
9.2.4.5.1.1. Market Estimation, 2015 - 2020
9.2.4.5.1.2. Market Forecast, 2021 - 2029
9.2.4.5.2.
Europe
9.2.4.5.2.1. Market Estimation, 2015 - 2020
9.2.4.5.2.2. Market Forecast, 2021 - 2029
9.2.4.5.3.
Asia
Pacific
9.2.4.5.3.1. Market Estimation, 2015 - 2020
9.2.4.5.3.2. Market Forecast, 2021 - 2029
9.2.4.5.4.
Middle
East and Africa
9.2.4.5.4.1. Market Estimation, 2015 - 2020
9.2.4.5.4.2. Market Forecast, 2021 - 2029
9.2.4.5.5.
Latin
America
9.2.4.5.5.1. Market Estimation, 2015 - 2020
9.2.4.5.5.2. Market Forecast, 2021 - 2029
9.3. Key Segment for Channeling Investments
9.3.1. By End-Users
10. Global Nutrigenomics Market Analysis and
Forecasts, 2021 – 2029
10.1. Overview
10.2. Global Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
10.2.1. Obesity
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 -
2020
10.2.1.3. Market Forecast, 2021 - 2029
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market Estimation, 2015 - 2020
10.2.1.5.1.2. Market Forecast, 2021 - 2029
10.2.1.5.2. Europe
10.2.1.5.2.1. Market Estimation, 2015 - 2020
10.2.1.5.2.2. Market Forecast, 2021 - 2029
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market Estimation, 2015 - 2020
10.2.1.5.3.2. Market Forecast, 2021 - 2029
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market Estimation, 2015 - 2020
10.2.1.5.4.2. Market Forecast, 2021 - 2029
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market Estimation, 2015 - 2020
10.2.1.5.5.2. Market Forecast, 2021 - 2029
10.2.2. Cardiovascular Disease (CVD)
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 -
2020
10.2.2.3. Market Forecast, 2021 - 2029
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market Estimation, 2015 - 2020
10.2.2.5.1.2. Market Forecast, 2021 - 2029
10.2.2.5.2. Europe
10.2.2.5.2.1. Market Estimation, 2015 - 2020
10.2.2.5.2.2. Market Forecast, 2021 - 2029
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market Estimation, 2015 - 2020
10.2.2.5.3.2. Market Forecast, 2021 - 2029
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market Estimation, 2015 - 2020
10.2.2.5.4.2. Market Forecast, 2021 - 2029
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market Estimation, 2015 - 2020
10.2.2.5.5.2. Market Forecast, 2021 - 2029
10.2.3. Diabetes Mellitus (DM)
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 -
2020
10.2.3.3. Market Forecast, 2021 - 2029
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market Estimation, 2015 - 2020
10.2.3.5.1.2. Market Forecast, 2021 - 2029
10.2.3.5.2. Europe
10.2.3.5.2.1. Market Estimation, 2015 - 2020
10.2.3.5.2.2. Market Forecast, 2021 - 2029
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market Estimation, 2015 - 2020
10.2.3.5.3.2. Market Forecast, 2021 - 2029
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market Estimation, 2015 - 2020
10.2.3.5.4.2. Market Forecast, 2021 - 2029
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market Estimation, 2015 - 2020
10.2.3.5.5.2. Market Forecast, 2021 - 2029
10.2.4. Cancer
10.2.4.1. Definition
10.2.4.2. Market Estimation and Penetration, 2015 -
2020
10.2.4.3. Market Forecast, 2021 - 2029
10.2.4.4. Compound Annual Growth Rate (CAGR)
10.2.4.5. Regional Bifurcation
10.2.4.5.1. North America
10.2.4.5.1.1. Market Estimation, 2015 - 2020
10.2.4.5.1.2. Market Forecast, 2021 - 2029
10.2.4.5.2. Europe
10.2.4.5.2.1. Market Estimation, 2015 - 2020
10.2.4.5.2.2. Market Forecast, 2021 - 2029
10.2.4.5.3. Asia Pacific
10.2.4.5.3.1. Market Estimation, 2015 - 2020
10.2.4.5.3.2. Market Forecast, 2021 - 2029
10.2.4.5.4. Middle East and Africa
10.2.4.5.4.1. Market Estimation, 2015 - 2020
10.2.4.5.4.2. Market Forecast, 2021 - 2029
10.2.4.5.5. Latin America
10.2.4.5.5.1. Market Estimation, 2015 - 2020
10.2.4.5.5.2. Market Forecast, 2021 - 2029
10.2.5. Others
10.2.5.1. Definition
10.2.5.2. Market Estimation and Penetration, 2015 -
2020
10.2.5.3. Market Forecast, 2021 - 2029
10.2.5.4. Compound Annual Growth Rate (CAGR)
10.2.5.5. Regional Bifurcation
10.2.5.5.1. North America
10.2.5.5.1.1. Market Estimation, 2015 - 2020
10.2.5.5.1.2. Market Forecast, 2021 - 2029
10.2.5.5.2. Europe
10.2.5.5.2.1. Market Estimation, 2015 - 2020
10.2.5.5.2.2. Market Forecast, 2021 - 2029
10.2.5.5.3. Asia Pacific
10.2.5.5.3.1. Market Estimation, 2015 - 2020
10.2.5.5.3.2. Market Forecast, 2021 - 2029
10.2.5.5.4. Middle East and Africa
10.2.5.5.4.1. Market Estimation, 2015 - 2020
10.2.5.5.4.2. Market Forecast, 2021 - 2029
10.2.5.5.5. Latin America
10.2.5.5.5.1. Market Estimation, 2015 - 2020
10.2.5.5.5.2. Market Forecast, 2021 - 2029
10.3. Key Segment for Channeling Investments
10.3.1. By Application
11. North America Nutrigenomics Market Analysis
and Forecasts, 2021 - 2029
11.1. Overview
11.1.1. North America Nutrigenomics Market Revenue
(US$ Mn)
11.2. North America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
11.2.1. Health Test
11.2.2. Sports Test
11.2.3. Fertility Test
11.2.4. Plant-Based
11.3. North America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
11.3.1. Clubs
11.3.2. Health and Fitness Professionals
11.3.3. Wellness Companies
11.3.4. Others
11.4. North America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
11.4.1. Obesity
11.4.2. Cardiovascular Disease (CVD)
11.4.3. Diabetes Mellitus (DM)
11.4.4. Cancer
11.4.5. Others
11.5. North America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
11.5.1. U.S
11.5.1.1. U.S Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By Type
11.5.1.1.1. Health Test
11.5.1.1.2. Sports Test
11.5.1.1.3. Fertility Test
11.5.1.1.4. Plant-Based
11.5.1.2. U.S Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By End-Users
11.5.1.2.1. Clubs
11.5.1.2.2. Health and Fitness Professionals
11.5.1.2.3. Wellness Companies
11.5.1.2.4. Others
11.5.1.3. U.S Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By Application
11.5.1.3.1. Obesity
11.5.1.3.2. Cardiovascular Disease (CVD)
11.5.1.3.3. Diabetes Mellitus (DM)
11.5.1.3.4. Cancer
11.5.1.3.5. Others
11.5.2. Canada
11.5.2.1. Canada Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
11.5.2.1.1. Health Test
11.5.2.1.2. Sports Test
11.5.2.1.3. Fertility Test
11.5.2.1.4. Plant-Based
11.5.2.2. Canada Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
11.5.2.2.1. Clubs
11.5.2.2.2. Health and Fitness Professionals
11.5.2.2.3. Wellness Companies
11.5.2.2.4. Others
11.5.2.3. Canada Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
11.5.2.3.1. Obesity
11.5.2.3.2. Cardiovascular Disease (CVD)
11.5.2.3.3. Diabetes Mellitus (DM)
11.5.2.3.4. Cancer
11.5.2.3.5. Others
11.5.3. Mexico
11.5.3.1. Mexico Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
11.5.3.1.1. Health Test
11.5.3.1.2. Sports Test
11.5.3.1.3. Fertility Test
11.5.3.1.4. Plant-Based
11.5.3.2. Mexico Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
11.5.3.2.1. Clubs
11.5.3.2.2. Health and Fitness Professionals
11.5.3.2.3. Wellness Companies
11.5.3.2.4. Others
11.5.3.3. Mexico Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
11.5.3.3.1. Obesity
11.5.3.3.2. Cardiovascular Disease (CVD)
11.5.3.3.3. Diabetes Mellitus (DM)
11.5.3.3.4. Cancer
11.5.3.3.5. Others
11.5.4. Rest of North America
11.5.4.1. Rest of North America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Type
11.5.4.1.1. Health Test
11.5.4.1.2. Sports Test
11.5.4.1.3. Fertility Test
11.5.4.1.4. Plant-Based
11.5.4.2. Rest of North America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
11.5.4.2.1. Clubs
11.5.4.2.2. Health and Fitness Professionals
11.5.4.2.3. Wellness Companies
11.5.4.2.4. Others
11.5.4.3. Rest of North America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Application
11.5.4.3.1. Obesity
11.5.4.3.2. Cardiovascular Disease (CVD)
11.5.4.3.3. Diabetes Mellitus (DM)
11.5.4.3.4. Cancer
11.5.4.3.5. Others
11.6. Key Segment for Channeling Investments
11.6.1. By Country
11.6.2. By Type
11.6.3. By End-Users
11.6.4. By Application
12. Europe Nutrigenomics Market Analysis and
Forecasts, 2021 - 2029
12.1. Overview
12.1.1. Europe Nutrigenomics Market Revenue (US$ Mn)
12.2. Europe Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.2.1. Health Test
12.2.2. Sports Test
12.2.3. Fertility Test
12.2.4. Plant-Based
12.3. Europe Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.3.1. Clubs
12.3.2. Health and Fitness Professionals
12.3.3. Wellness Companies
12.3.4. Others
12.4. Europe Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.4.1. Obesity
12.4.2. Cardiovascular Disease (CVD)
12.4.3. Diabetes Mellitus (DM)
12.4.4. Cancer
12.4.5. Others
12.5. Europe Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Country
12.5.1. France
12.5.1.1. France Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.5.1.1.1. Health Test
12.5.1.1.2. Sports Test
12.5.1.1.3. Fertility Test
12.5.1.1.4. Plant-Based
12.5.1.2. France Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.5.1.2.1. Clubs
12.5.1.2.2. Health and Fitness Professionals
12.5.1.2.3. Wellness Companies
12.5.1.2.4. Others
12.5.1.3. France Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.1.3.1. Obesity
12.5.1.3.2. Cardiovascular Disease (CVD)
12.5.1.3.3. Diabetes Mellitus (DM)
12.5.1.3.4. Cancer
12.5.1.3.5. Others
12.5.2. The UK
12.5.2.1. The UK Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.5.2.1.1. Health Test
12.5.2.1.2. Sports Test
12.5.2.1.3. Fertility Test
12.5.2.1.4. Plant-Based
12.5.2.2. The UK Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.5.2.2.1. Clubs
12.5.2.2.2. Health and Fitness Professionals
12.5.2.2.3. Wellness Companies
12.5.2.2.4. Others
12.5.2.3. The UK Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.2.3.1. Obesity
12.5.2.3.2. Cardiovascular Disease (CVD)
12.5.2.3.3. Diabetes Mellitus (DM)
12.5.2.3.4. Cancer
12.5.2.3.5. Others
12.5.3. Spain
12.5.3.1. Spain Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.5.3.1.1. Health Test
12.5.3.1.2. Sports Test
12.5.3.1.3. Fertility Test
12.5.3.1.4. Plant-Based
12.5.3.2. Spain Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.5.3.2.1. Clubs
12.5.3.2.2. Health and Fitness Professionals
12.5.3.2.3. Wellness Companies
12.5.3.2.4. Others
12.5.3.3. Spain Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.3.3.1. Obesity
12.5.3.3.2. Cardiovascular Disease (CVD)
12.5.3.3.3. Diabetes Mellitus (DM)
12.5.3.3.4. Cancer
12.5.3.3.5. Others
12.5.4. Germany
12.5.4.1. Germany Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.5.4.1.1. Health Test
12.5.4.1.2. Sports Test
12.5.4.1.3. Fertility Test
12.5.4.1.4. Plant-Based
12.5.4.2. Germany Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
12.5.4.2.1. Clubs
12.5.4.2.2. Health and Fitness Professionals
12.5.4.2.3. Wellness Companies
12.5.4.2.4. Others
12.5.4.3. Germany Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.4.3.1. Obesity
12.5.4.3.2. Cardiovascular Disease (CVD)
12.5.4.3.3. Diabetes Mellitus (DM)
12.5.4.3.4. Cancer
12.5.4.3.5. Others
12.5.5. Italy
12.5.5.1. Italy Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
12.5.5.1.1. Health Test
12.5.5.1.2. Sports Test
12.5.5.1.3. Fertility Test
12.5.5.1.4. Plant-Based
12.5.5.2. Italy Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By End-Users
12.5.5.2.1. Clubs
12.5.5.2.2. Health and Fitness Professionals
12.5.5.2.3. Wellness Companies
12.5.5.2.4. Others
12.5.5.3. Italy Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
12.5.5.3.1. Obesity
12.5.5.3.2. Cardiovascular Disease (CVD)
12.5.5.3.3. Diabetes Mellitus (DM)
12.5.5.3.4. Cancer
12.5.5.3.5. Others
12.5.6. Nordic Countries
12.5.6.1. Nordic Countries Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.6.1.1. Health Test
12.5.6.1.2. Sports Test
12.5.6.1.3. Fertility Test
12.5.6.1.4. Plant-Based
12.5.6.2. Nordic Countries Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
12.5.6.2.1. Clubs
12.5.6.2.2. Health and Fitness Professionals
12.5.6.2.3. Wellness Companies
12.5.6.2.4. Others
12.5.6.3. Nordic Countries Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
12.5.6.3.1. Obesity
12.5.6.3.2. Cardiovascular Disease (CVD)
12.5.6.3.3. Diabetes Mellitus (DM)
12.5.6.3.4. Cancer
12.5.6.3.5. Others
12.5.6.4. Nordic Countries Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux Union
12.5.7.1. Benelux Union Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.7.1.1. Health Test
12.5.7.1.2. Sports Test
12.5.7.1.3. Fertility Test
12.5.7.1.4. Plant-Based
12.5.7.2. Benelux Union Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
12.5.7.2.1. Clubs
12.5.7.2.2. Health and Fitness Professionals
12.5.7.2.3. Wellness Companies
12.5.7.2.4. Others
12.5.7.3. Benelux Union Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
12.5.7.3.1. Obesity
12.5.7.3.2. Cardiovascular Disease (CVD)
12.5.7.3.3. Diabetes Mellitus (DM)
12.5.7.3.4. Cancer
12.5.7.3.5. Others
12.5.7.4. Benelux Union Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of Europe
12.5.8.1. Rest of Europe Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
12.5.8.1.1. Health Test
12.5.8.1.2. Sports Test
12.5.8.1.3. Fertility Test
12.5.8.1.4. Plant-Based
12.5.8.2. Rest of Europe Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
12.5.8.2.1. Clubs
12.5.8.2.2. Health and Fitness Professionals
12.5.8.2.3. Wellness Companies
12.5.8.2.4. Others
12.5.8.3. Rest of Europe Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
12.5.8.3.1. Obesity
12.5.8.3.2. Cardiovascular Disease (CVD)
12.5.8.3.3. Diabetes Mellitus (DM)
12.5.8.3.4. Cancer
12.5.8.3.5. Others
12.6. Key Segment for Channeling Investments
12.6.1. By Country
12.6.2. By Type
12.6.3. By End-Users
12.6.4. By Application
13. Asia Pacific Nutrigenomics Market Analysis
and Forecasts, 2021 - 2029
13.1. Overview
13.1.1. Asia Pacific Nutrigenomics Market Revenue
(US$ Mn)
13.2. Asia Pacific Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
13.2.1. Health Test
13.2.2. Sports Test
13.2.3. Fertility Test
13.2.4. Plant-Based
13.3. Asia Pacific Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
13.3.1. Clubs
13.3.2. Health and Fitness Professionals
13.3.3. Wellness Companies
13.3.4. Others
13.4. Asia Pacific Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
13.4.1. Obesity
13.4.2. Cardiovascular Disease (CVD)
13.4.3. Diabetes Mellitus (DM)
13.4.4. Cancer
13.4.5. Others
13.5. Asia Pacific Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
13.5.1. China
13.5.1.1. China Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
13.5.1.1.1. Health Test
13.5.1.1.2. Sports Test
13.5.1.1.3. Fertility Test
13.5.1.1.4. Plant-Based
13.5.1.2. China Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
13.5.1.2.1. Clubs
13.5.1.2.2. Health and Fitness Professionals
13.5.1.2.3. Wellness Companies
13.5.1.2.4. Others
13.5.1.3. China Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.1.3.1. Obesity
13.5.1.3.2. Cardiovascular Disease (CVD)
13.5.1.3.3. Diabetes Mellitus (DM)
13.5.1.3.4. Cancer
13.5.1.3.5. Others
13.5.2. Japan
13.5.2.1. Japan Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
13.5.2.1.1. Health Test
13.5.2.1.2. Sports Test
13.5.2.1.3. Fertility Test
13.5.2.1.4. Plant-Based
13.5.2.2. Japan Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
13.5.2.2.1. Clubs
13.5.2.2.2. Health and Fitness Professionals
13.5.2.2.3. Wellness Companies
13.5.2.2.4. Others
13.5.2.3. Japan Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.2.3.1. Obesity
13.5.2.3.2. Cardiovascular Disease (CVD)
13.5.2.3.3. Diabetes Mellitus (DM)
13.5.2.3.4. Cancer
13.5.2.3.5. Others
13.5.3. India
13.5.3.1. India Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
13.5.3.1.1. Health Test
13.5.3.1.2. Sports Test
13.5.3.1.3. Fertility Test
13.5.3.1.4. Plant-Based
13.5.3.2. India Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
13.5.3.2.1. Clubs
13.5.3.2.2. Health and Fitness Professionals
13.5.3.2.3. Wellness Companies
13.5.3.2.4. Others
13.5.3.3. India Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
13.5.3.3.1. Obesity
13.5.3.3.2. Cardiovascular Disease (CVD)
13.5.3.3.3. Diabetes Mellitus (DM)
13.5.3.3.4. Cancer
13.5.3.3.5. Others
13.5.4. New Zealand
13.5.4.1. New Zealand Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Type
13.5.4.1.1. Health Test
13.5.4.1.2. Sports Test
13.5.4.1.3. Fertility Test
13.5.4.1.4. Plant-Based
13.5.4.2. New Zealand Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By End-Users
13.5.4.2.1. Clubs
13.5.4.2.2. Health and Fitness Professionals
13.5.4.2.3. Wellness Companies
13.5.4.2.4. Others
13.5.4.3. New Zealand Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Application
13.5.4.3.1. Obesity
13.5.4.3.2. Cardiovascular Disease (CVD)
13.5.4.3.3. Diabetes Mellitus (DM)
13.5.4.3.4. Cancer
13.5.4.3.5. Others
13.5.5. Australia
13.5.5.1. Australia Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Type
13.5.5.1.1. Health Test
13.5.5.1.2. Sports Test
13.5.5.1.3. Fertility Test
13.5.5.1.4. Plant-Based
13.5.5.2. Australia Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By End-Users
13.5.5.2.1. Clubs
13.5.5.2.2. Health and Fitness Professionals
13.5.5.2.3. Wellness Companies
13.5.5.2.4. Others
13.5.5.3. Australia Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Application
13.5.5.3.1. Obesity
13.5.5.3.2. Cardiovascular Disease (CVD)
13.5.5.3.3. Diabetes Mellitus (DM)
13.5.5.3.4. Cancer
13.5.5.3.5. Others
13.5.6. South Korea
13.5.6.1. South Korea Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Type
13.5.6.1.1. Health Test
13.5.6.1.2. Sports Test
13.5.6.1.3. Fertility Test
13.5.6.1.4. Plant-Based
13.5.6.2. South Korea Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By End-Users
13.5.6.2.1. Clubs
13.5.6.2.2. Health and Fitness Professionals
13.5.6.2.3. Wellness Companies
13.5.6.2.4. Others
13.5.6.3. South Korea Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Application
13.5.6.3.1. Obesity
13.5.6.3.2. Cardiovascular Disease (CVD)
13.5.6.3.3. Diabetes Mellitus (DM)
13.5.6.3.4. Cancer
13.5.6.3.5. Others
13.5.7. Southeast Asia
13.5.7.1. Southeast Asia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
13.5.7.1.1. Health Test
13.5.7.1.2. Sports Test
13.5.7.1.3. Fertility Test
13.5.7.1.4. Plant-Based
13.5.7.2. Southeast Asia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
13.5.7.2.1. Clubs
13.5.7.2.2. Health and Fitness Professionals
13.5.7.2.3. Wellness Companies
13.5.7.2.4. Others
13.5.7.3. Southeast Asia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
13.5.7.3.1. Obesity
13.5.7.3.2. Cardiovascular Disease (CVD)
13.5.7.3.3. Diabetes Mellitus (DM)
13.5.7.3.4. Cancer
13.5.7.3.5. Others
13.5.7.4. Southeast Asia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of Asia Pacific
13.5.8.1. Rest of Asia Pacific Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Type
13.5.8.1.1. Health Test
13.5.8.1.2. Sports Test
13.5.8.1.3. Fertility Test
13.5.8.1.4. Plant-Based
13.5.8.2. Rest of Asia Pacific Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
13.5.8.2.1. Clubs
13.5.8.2.2. Health and Fitness Professionals
13.5.8.2.3. Wellness Companies
13.5.8.2.4. Others
13.5.8.3. Rest of Asia Pacific Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Application
13.5.8.3.1. Obesity
13.5.8.3.2. Cardiovascular Disease (CVD)
13.5.8.3.3. Diabetes Mellitus (DM)
13.5.8.3.4. Cancer
13.5.8.3.5. Others
13.6. Key Segment for Channeling Investments
13.6.1. By Country
13.6.2. By Type
13.6.3. By End-Users
13.6.4. By Application
14. Middle East and Africa Nutrigenomics Market
Analysis and Forecasts, 2021 - 2029
14.1. Overview
14.1.1. Middle East and Africa Nutrigenomics Market
Revenue (US$ Mn)
14.2. Middle East and Africa Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Type
14.2.1. Health Test
14.2.2. Sports Test
14.2.3. Fertility Test
14.2.4. Plant-Based
14.3. Middle East and Africa Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
14.3.1. Clubs
14.3.2. Health and Fitness Professionals
14.3.3. Wellness Companies
14.3.4. Others
14.4. Middle East and Africa Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Application
14.4.1. Obesity
14.4.2. Cardiovascular Disease (CVD)
14.4.3. Diabetes Mellitus (DM)
14.4.4. Cancer
14.4.5. Others
14.5. Middle East and Africa Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Country
14.5.1. Saudi Arabia
14.5.1.1. Saudi Arabia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
14.5.1.1.1. Health Test
14.5.1.1.2. Sports Test
14.5.1.1.3. Fertility Test
14.5.1.1.4. Plant-Based
14.5.1.2. Saudi Arabia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
14.5.1.2.1. Clubs
14.5.1.2.2. Health and Fitness Professionals
14.5.1.2.3. Wellness Companies
14.5.1.2.4. Others
14.5.1.3. Saudi Arabia Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
14.5.1.3.1. Obesity
14.5.1.3.2. Cardiovascular Disease (CVD)
14.5.1.3.3. Diabetes Mellitus (DM)
14.5.1.3.4. Cancer
14.5.1.3.5. Others
14.5.2. UAE
14.5.2.1. UAE Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By Type
14.5.2.1.1. Health Test
14.5.2.1.2. Sports Test
14.5.2.1.3. Fertility Test
14.5.2.1.4. Plant-Based
14.5.2.2. UAE Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By End-Users
14.5.2.2.1. Clubs
14.5.2.2.2. Health and Fitness Professionals
14.5.2.2.3. Wellness Companies
14.5.2.2.4. Others
14.5.2.3. UAE Nutrigenomics Market Revenue (US$ Mn) and
Forecasts, By Application
14.5.2.3.1. Obesity
14.5.2.3.2. Cardiovascular Disease (CVD)
14.5.2.3.3. Diabetes Mellitus (DM)
14.5.2.3.4. Cancer
14.5.2.3.5. Others
14.5.3. Egypt
14.5.3.1. Egypt Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
14.5.3.1.1. Health Test
14.5.3.1.2. Sports Test
14.5.3.1.3. Fertility Test
14.5.3.1.4. Plant-Based
14.5.3.2. Egypt Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
14.5.3.2.1. Clubs
14.5.3.2.2. Health and Fitness Professionals
14.5.3.2.3. Wellness Companies
14.5.3.2.4. Others
14.5.3.3. Egypt Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
14.5.3.3.1. Obesity
14.5.3.3.2. Cardiovascular Disease (CVD)
14.5.3.3.3. Diabetes Mellitus (DM)
14.5.3.3.4. Cancer
14.5.3.3.5. Others
14.5.4. Kuwait
14.5.4.1. Kuwait Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
14.5.4.1.1. Health Test
14.5.4.1.2. Sports Test
14.5.4.1.3. Fertility Test
14.5.4.1.4. Plant-Based
14.5.4.2. Kuwait Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
14.5.4.2.1. Clubs
14.5.4.2.2. Health and Fitness Professionals
14.5.4.2.3. Wellness Companies
14.5.4.2.4. Others
14.5.4.3. Kuwait Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
14.5.4.3.1. Obesity
14.5.4.3.2. Cardiovascular Disease (CVD)
14.5.4.3.3. Diabetes Mellitus (DM)
14.5.4.3.4. Cancer
14.5.4.3.5. Others
14.5.5. South Africa
14.5.5.1. South Africa Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
14.5.5.1.1. Health Test
14.5.5.1.2. Sports Test
14.5.5.1.3. Fertility Test
14.5.5.1.4. Plant-Based
14.5.5.2. South Africa Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
14.5.5.2.1. Clubs
14.5.5.2.2. Health and Fitness Professionals
14.5.5.2.3. Wellness Companies
14.5.5.2.4. Others
14.5.5.3. South Africa Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
14.5.5.3.1. Obesity
14.5.5.3.2. Cardiovascular Disease (CVD)
14.5.5.3.3. Diabetes Mellitus (DM)
14.5.5.3.4. Cancer
14.5.5.3.5. Others
14.5.6. Rest of Middle East & Africa
14.5.6.1. Rest of Middle East & Africa
Nutrigenomics Market Revenue (US$ Mn) and Forecasts, By Type
14.5.6.1.1. Health Test
14.5.6.1.2. Sports Test
14.5.6.1.3. Fertility Test
14.5.6.1.4. Plant-Based
14.5.6.2. Rest of Middle East & Africa
Nutrigenomics Market Revenue (US$ Mn) and Forecasts, By End-Users
14.5.6.2.1. Clubs
14.5.6.2.2. Health and Fitness Professionals
14.5.6.2.3. Wellness Companies
14.5.6.2.4. Others
14.5.6.3. Rest of Middle East & Africa
Nutrigenomics Market Revenue (US$ Mn) and Forecasts, By Application
14.5.6.3.1. Obesity
14.5.6.3.2. Cardiovascular Disease (CVD)
14.5.6.3.3. Diabetes Mellitus (DM)
14.5.6.3.4. Cancer
14.5.6.3.5. Others
14.6. Key Segment for Channeling Investments
14.6.1. By Country
14.6.2. By Type
14.6.3. By End-Users
14.6.4. By Application
15. Latin America Nutrigenomics Market Analysis
and Forecasts, 2021 - 2029
15.1. Overview
15.1.1. Latin America Nutrigenomics Market Revenue
(US$ Mn)
15.2. Latin America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Type
15.2.1. Health Test
15.2.2. Sports Test
15.2.3. Fertility Test
15.2.4. Plant-Based
15.3. Latin America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By End-Users
15.3.1. Clubs
15.3.2. Health and Fitness Professionals
15.3.3. Wellness Companies
15.3.4. Others
15.4. Latin America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Application
15.4.1. Obesity
15.4.2. Cardiovascular Disease (CVD)
15.4.3. Diabetes Mellitus (DM)
15.4.4. Cancer
15.4.5. Others
15.5. Latin America Nutrigenomics Market Revenue
(US$ Mn) and Forecasts, By Country
15.5.1. Brazil
15.5.1.1. Brazil Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Type
15.5.1.1.1. Health Test
15.5.1.1.2. Sports Test
15.5.1.1.3. Fertility Test
15.5.1.1.4. Plant-Based
15.5.1.2. Brazil Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By End-Users
15.5.1.2.1. Clubs
15.5.1.2.2. Health and Fitness Professionals
15.5.1.2.3. Wellness Companies
15.5.1.2.4. Others
15.5.1.3. Brazil Nutrigenomics Market Revenue (US$ Mn)
and Forecasts, By Application
15.5.1.3.1. Obesity
15.5.1.3.2. Cardiovascular Disease (CVD)
15.5.1.3.3. Diabetes Mellitus (DM)
15.5.1.3.4. Cancer
15.5.1.3.5. Others
15.5.2. Argentina
15.5.2.1. Argentina Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Type
15.5.2.1.1. Health Test
15.5.2.1.2. Sports Test
15.5.2.1.3. Fertility Test
15.5.2.1.4. Plant-Based
15.5.2.2. Argentina Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By End-Users
15.5.2.2.1. Clubs
15.5.2.2.2. Health and Fitness Professionals
15.5.2.2.3. Wellness Companies
15.5.2.2.4. Others
15.5.2.3. Argentina Nutrigenomics Market Revenue (US$
Mn) and Forecasts, By Application
15.5.2.3.1. Obesity
15.5.2.3.2. Cardiovascular Disease (CVD)
15.5.2.3.3. Diabetes Mellitus (DM)
15.5.2.3.4. Cancer
15.5.2.3.5. Others
15.5.3. Rest of Latin America
15.5.3.1. Rest of Latin America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Type
15.5.3.1.1. Health Test
15.5.3.1.2. Sports Test
15.5.3.1.3. Fertility Test
15.5.3.1.4. Plant-Based
15.5.3.2. Rest of Latin America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By End-Users
15.5.3.2.1. Clubs
15.5.3.2.2. Health and Fitness Professionals
15.5.3.2.3. Wellness Companies
15.5.3.2.4. Others
15.5.3.3. Rest of Latin America Nutrigenomics Market
Revenue (US$ Mn) and Forecasts, By Application
15.5.3.3.1. Obesity
15.5.3.3.2. Cardiovascular Disease (CVD)
15.5.3.3.3. Diabetes Mellitus (DM)
15.5.3.3.4. Cancer
15.5.3.3.5. Others
15.6. Key Segment for Channeling Investments
15.6.1. By Country
15.6.2. By Type
15.6.3. By End-Users
15.6.4. By Application
16. Competitive Benchmarking
16.1. Brand Benchmarking
16.2. Market Share Analysis, 2020
16.3. Global Presence and Growth Strategies
16.3.1. Mergers and Acquisitions
16.3.2. Product Launches
16.3.3. Investments Trends
16.3.4. R&D Initiatives
17. Player Profiles
17.1. Alltech
17.1.1. Company Details
17.1.2. Company Overview
17.1.3. Product Offerings
17.1.4. Key Developments
17.1.5. Financial Analysis
17.1.6. SWOT Analysis
17.1.7. Business Strategies
17.2. Cell-Logic
17.2.1. Company Details
17.2.2. Company Overview
17.2.3. Product Offerings
17.2.4. Key Developments
17.2.5. Financial Analysis
17.2.6. SWOT Analysis
17.2.7. Business Strategies
17.3. Cura Integrative Medicine
17.3.1. Company Details
17.3.2. Company Overview
17.3.3. Product Offerings
17.3.4. Key Developments
17.3.5. Financial Analysis
17.3.6. SWOT Analysis
17.3.7. Business Strategies
17.4. geneOmbio Technologies Pvt. Ltd.
17.4.1. Company Details
17.4.2. Company Overview
17.4.3. Product Offerings
17.4.4. Key Developments
17.4.5. Financial Analysis
17.4.6. SWOT Analysis
17.4.7. Business Strategies
17.5. Genova Diagnostics (GDX)
17.5.1. Company Details
17.5.2. Company Overview
17.5.3. Product Offerings
17.5.4. Key Developments
17.5.5. Financial Analysis
17.5.6. SWOT Analysis
17.5.7. Business Strategies
17.6. Genova Diagnostics
17.6.1. Company Details
17.6.2. Company Overview
17.6.3. Product Offerings
17.6.4. Key Developments
17.6.5. Financial Analysis
17.6.6. SWOT Analysis
17.6.7. Business Strategies
17.7. Metagenics, Inc.
17.7.1. Company Details
17.7.2. Company Overview
17.7.3. Product Offerings
17.7.4. Key Developments
17.7.5. Financial Analysis
17.7.6. SWOT Analysis
17.7.7. Business Strategies
17.8. Nutrigenomix
17.8.1. Company Details
17.8.2. Company Overview
17.8.3. Product Offerings
17.8.4. Key Developments
17.8.5. Financial Analysis
17.8.6. SWOT Analysis
17.8.7. Business Strategies
17.9. Sanger Genomics Pvt. Ltd
17.9.1. Company Details
17.9.2. Company Overview
17.9.3. Product Offerings
17.9.4. Key Developments
17.9.5. Financial Analysis
17.9.6. SWOT Analysis
17.9.7. Business Strategies
17.10. Wellgen Medical Co., Ltd.
17.10.1. Company Details
17.10.2. Company Overview
17.10.3. Product Offerings
17.10.4. Key Developments
17.10.5. Financial Analysis
17.10.6. SWOT Analysis
17.10.7. Business Strategies
17.11. Other Market Participants
18. Key Findings
**Exclusive for Multi-User and
Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.